News
19h
Clinical Trials Arena on MSNSellas doses first paediatric subject with AML in Phase II trial of SLS009Sellas Life Sciences has dosed the first paediatric subject with acute myeloid leukaemia (AML) in its multi-centre Phase II ...
The FDA also approved the use of Zynyz as a monotherapy for patients with squamous cell carcinoma of the anal canal who are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results